Optimi Health (NASDAQ:OPTH – Get Free Report) was upgraded by analysts at Wall Street Zen to a “hold” rating in a research note issued to investors on Saturday.
A number of other research analysts also recently issued reports on OPTH. Zacks Research upgraded shares of Optimi Health to a “hold” rating in a research note on Thursday, May 28th. Weiss Ratings started coverage on shares of Optimi Health in a research report on Thursday, May 21st. They issued a “sell (d-)” rating on the stock. One investment analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Reduce”.
Check Out Our Latest Stock Analysis on OPTH
Optimi Health Price Performance
Read More
- Five stocks we like better than Optimi Health
- AMD and Cerbras Create A New Blueprint For Hardware
- Intel Earnings Reveal Whether the Chip Selloff Created a Buy
- CrowdStrike’s Cerebras Deal Puts Its AI Security Strategy to the Test
- Plugging In: How Kinder Morgan Powers Up Profits
Receive News & Ratings for Optimi Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Optimi Health and related companies with MarketBeat.com's FREE daily email newsletter.
